Srikanth Krishnan is a Cardiology physician affiliated with University of California, Los Angeles. OpenAlex indexes 67 publications with 228 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 Ucla Medical Plz Ste 630
Los Angeles, CA 900246997
Telephone
310-825-9011Provider last certified this registry record 2 Jan 2025.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- HEARTFLOW, INC.Program year202515 payments
- Edwards Lifesciences CorporationProgram year20251 payment
- HEARTFLOW, INC.Program year202412 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Statin100%Atorvastatin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effect of colchicine on progression of known coronary atherosclerosis in patients with stable coronary artery disease: EKSTROM randomized placebo controlled trial
European Heart Journal - Cardiovascular Imaging
2026 - 26-A-20880-ACC THE EFFECT OF COLCHICINE ON EPICARDIAL ADIPOSE TISSUE BY SERIAL CCTA: INSIGHTS FROM THE EKSTROM TRIAL
Journal of the American College of Cardiology
2026 - 26-A-18640-ACC STATIN UTILIZATION BY SOCIAL DEPRIVATION INDEX IN PATIENTS WITH ELEVATED CAC SCORES IN LOS ANGELES COUNTY
Journal of the American College of Cardiology
2026 - 26-A-14094-ACC OBESITY IS ASSOCIATED WITH FASTER CORONARY ARTERY CALCIUM PROGRESSION AMONG STATIN USERS
Journal of the American College of Cardiology
2026 - NATURal history of coronary PlaquE on cardiac computed tomography in individuals without MACE or lipid-lowering therapy: NATURE-CTstudy
Journal of cardiovascular computed tomography
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”